Chemed appoints Michael Witzeman as CFO effective Jan 1, 2024, succeeding retiring David P. Williams

CHEMED CORP

Michael Witzeman appointed CFO, effective January 1, 2024, replacing David P. Williams who is retiring.
Witzeman is currently Chemed's Vice President, Controller, and principal accounting officer.
He joined Chemed in 2005; previously Senior Manager at Deloitte & Touche; holds CPA, BBA, MBA.
No other officer changes or compensation adjustments disclosed in the filing.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Witzeman

Chief Financial Officer

CHE · CHEMED CORP

Effective: 2024-01-01
Filed: December 18, 2023, 6:59 PM ET

On December 18 th , the Company’s Board of Directors appointed Michael Witzeman as the Company’s Chief Financial Officer, effective as of January 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Witzeman was appointed as Chief Financial Officer at CHEMED CORP.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On December 18 th , the Company’s Board of Directors appointed Michael Witzeman as the Company’s Chief Financial Officer, effective as of January 1, 2024.

View on SEC.gov

CHEMED CORP filing history →

Source: SEC EDGAR

accession 0001562762-23-000442

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.